Diabetes 54:2365-2374, 2005
© 2005 by the American Diabetes Association, Inc.
Skeletal Muscle AMP-Activated Protein Kinase Phosphorylation Parallels Metabolic Phenotype in Leptin Transgenic Mice Under Dietary Modification
Tomohiro Tanaka1,
Shuji Hidaka1,2,
Hiroaki Masuzaki1,
Shintaro Yasue1,
Yasuhiko Minokoshi3,
Ken Ebihara1,
Hideki Chusho1,
Yoshihiro Ogawa4,
Taro Toyoda5,
Kenji Sato6,
Fumiko Miyanaga1,
Muneya Fujimoto1,
Tsutomu Tomita1,
Toru Kusakabe1,
Nozomi Kobayashi1,
Hideki Tanioka1,
Tatsuya Hayashi7,
Kiminori Hosoda1,
Hironobu Yoshimatsu2,
Toshiie Sakata2, and
Kazuwa Nakao1
1 Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
2 Department of Internal Medicine, School of Medicine, Oita University, Oita, Japan
3 Department of Developmental Physiology, National Institute for Physiological Sciences, Okazaki, Japan
4 Department of Molecular Medicine and Metabolism, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
5 Division of Food Science and Biotechnology, Kyoto University Graduate School of Agriculture, Kyoto, Japan
6 Department of Food Sciences and Nutritional Health, Kyoto Prefectural University, Kyoto, Japan
7 Department of Human Coexistence, Kyoto University Graduate School of Human and Environmental Studies, Kyoto, Japan
Leptin augments glucose and lipid metabolism independent of its effect on satiety. Administration of leptin in rodents increases skeletal muscle ß-oxidation by activating AMP-activated protein kinase (AMPK). We previously reported that, as hyperleptinemic as obese human subjects, transgenic skinny mice overexpressing leptin in liver (LepTg) exhibit enhanced insulin sensitivity and lipid clearance. To assess skeletal muscle AMPK activity in leptin-sensitive and -insensitive states, we examined phosphorylation of AMPK and its target, acetyl CoA carboxylase (ACC), in muscles from LepTg under dietary modification. Here we show that phosphorylation of AMPK and ACC are chronically augmented in LepTg soleus muscle, with a concomitant increase in the AMP-to-ATP ratio and a significant decrease in tissue triglyceride content. Despite preexisting hyperleptinemia, high-fat diet (HFD)-fed LepTg develop obesity, insulin-resistance, and hyperlipidemia. In parallel, elevated soleus AMPK and ACC phosphorylation in regular diet–fed LepTg is attenuated, and tissue triglyceride content is increased in those given HFD. Of note, substitution of HFD with regular diet causes a robust recovery of soleus AMPK and ACC phosphorylation in LepTg, with a higher rate of body weight reduction and a regain of insulin sensitivity. In conclusion, soleus AMPK and ACC phosphorylation in LepTg changes in parallel with its insulin sensitivity under dietary modification, suggesting a close association between skeletal muscle AMPK activity and sensitivity to leptin.
Address correspondence and reprint requests to Hiroaki Masuzaki, MD, PhD, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan. E-mail: hiroaki{at}kuhp.kyoto-u.ac.jp
Abbreviations:
ACC, acetyl CoA carboxylase; AMPK, AMP-activated protein kinase; DIO, diet-induced obesity; EDL, extensor digitorum longus; FFA, free fatty acid; GTT, glucose tolerance test; HFD, high-fat diet; ITT, insulin tolerance test; SCD-1, stearoyl CoA desaturase-1; UCP-1, uncoupling protein-1

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Arai, H. Masuzaki, T. Tanaka, T. Ishii, S. Yasue, N. Kobayashi, T. Tomita, M. Noguchi, T. Kusakabe, J. Fujikura, et al.
Ceramide and Adenosine 5'-Monophosphate-Activated Protein Kinase Are Two Novel Regulators of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity in Cultured Preadipocytes
Endocrinology,
November 1, 2007;
148(11):
5268 - 5277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Rizki, L. Arnaboldi, B. Gabrielli, J. Yan, G. S. Lee, R. K. Ng, S. M. Turner, T. M. Badger, R. E. Pitas, and J. J. Maher
Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1
J. Lipid Res.,
October 1, 2006;
47(10):
2280 - 2290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Makino, Y. Miyamoto, K. Sawai, K. Mori, M. Mukoyama, K. Nakao, Y. Yoshimasa, and S.-i. Suga
Altered Gene Expression Related to Glomerulogenesis and Podocyte Structure in Early Diabetic Nephropathy of db/db Mice and Its Restoration by Pioglitazone.
Diabetes,
October 1, 2006;
55(10):
2747 - 2756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Martin, T. Alquier, K. Asakura, N. Furukawa, F. Preitner, and B. B. Kahn
Diet-induced Obesity Alters AMP Kinase Activity in Hypothalamus and Skeletal Muscle
J. Biol. Chem.,
July 14, 2006;
281(28):
18933 - 18941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Xue and B. B. Kahn
AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues
J. Physiol.,
July 1, 2006;
574(1):
73 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fediuc, M. P. Gaidhu, and R. B. Ceddia
Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells
J. Lipid Res.,
February 1, 2006;
47(2):
412 - 420.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|